Neurogenesis in Later Life: What the Brain’s Capacity for New Neurons Means for Us Older People
For decades the adult human brain was treated as a finished product. Neurons formed in the womb and early years; thereafter the organ could rewire connections but not add new cells. Recent evidence has overturned that view. Adult neurogenesis, the generation of new neurons, occurs in the hippocampus, the region central to learning and memory, and continues into advanced age. For older people this finding is not merely academic. It reframes cognitive aging as potentially modifiable rather than inevitable and points to practical ways of supporting brain health.
Researchers at the Karolinska Institute examined hippocampal tissue from people who had died between infancy and adulthood. Using single-cell genetic analysis and machine-learning models, they identified rare proliferating progenitor cells, the intermediate cells that divide to produce immature neurons. These progenitors were present in adult samples, demonstrating active neurogenesis rather than merely the persistence of immature cells formed earlier in life. Other groups have detected immature neurons in hippocampi from individuals up to age 92. The process is sparse and declines with age, yet it does not cease.
The functional significance appears tied to cognitive performance. In one study, "superagers," people in their eighties or older who outperform younger adults on memory tests, had roughly twice as many immature hippocampal neurons as cognitively normal older adults. Individuals with Alzheimer's disease had almost none. Some superagers also showed the plaques and tangles of Alzheimer's pathology yet retained superior memory, suggesting that higher levels of neurogenesis may help the brain compensate for or bypass damage. Neurogenesis is also reduced in Parkinson's disease and depression; animal work indicates that hippocampal neurogenesis supports pattern separation, the ability to distinguish similar experiences, which is impaired in several psychiatric conditions.
These observations carry direct implications for older adults. Age-related cognitive decline is not solely the result of irreversible neuronal loss. A residual capacity for new neuron production exists and appears protective when it is preserved. Stimulating that capacity could therefore serve as a shield against dementia or as an adjunct to recovery after stroke. Clinical trials exploring neurogenesis-related approaches are already under way. Existing medications, including certain antidepressants and the diabetes drug metformin, have shown the ability to increase neurogenesis in experimental settings.
Lifestyle interventions remain the most immediately accessible route. In rodents, voluntary running reliably increases hippocampal neurogenesis and improves maze performance; environmental enrichment (social contact, novel objects) has similar effects. Human evidence is less definitive but consistent in direction. Aerobic exercise programs in older adults have increased hippocampal volume and improved memory, effects thought to involve elevated brain-derived neurotrophic factor (BDNF) and improved vascular support for the neurogenic niche. Learning new skills, maintaining social engagement, and avoiding chronic stress are likewise associated with better cognitive trajectories and, by extension, conditions that favour residual neurogenesis.
The practical message for us older people is therefore straightforward. The brain retains a limited but genuine ability to generate new neurons well into later life. That ability is linked to memory performance and appears diminished in neurodegenerative and mood disorders. While pharmaceutical strategies to amplify it are still experimental, ordinary habits, regular aerobic activity, continued learning, and social connection, align with the biological conditions that support it. The discovery does not promise the restoration of youthful cognition, but it removes the justification for regarding the aging brain as incapable of renewal. For those seeking to protect cognitive function, the evidence now favours treating neurogenesis as a resource that can still be harnessed. And that's good news for people like me with an ageing brain.
